A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers

Journal of Psychopharmacology

Volumn 25, Issue 3, 2011, Pages 361-369

  Jacobs, G E ^a   Van Gerven, Jma ^a   De Kam, M L ^a   Elassaiss Schaap, J ^b   Ruigt, G ^b   Van Pelt, J ^c   Peeters, Bwmm ^b   Peeters, Pam ^b   Hulskotte, Egj ^b  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

desmopressin; function test; hypothalamus pituitary adrenal axis; stress related psychopathology; vasopressin

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CRH; DESMOPRESSIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ASSESSMENT; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FACIAL FLUSHING; FEMALE; FLUSHING; FUNCTION TEST; HEADACHE; HEART PALPITATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MAXIMUM PLASMA CONCENTRATION; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; URINALYSIS;

ADOLESCENT; ADULT; CORTICOTROPIN-RELEASING HORMONE; CROSS-OVER STUDIES; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; YOUNG ADULT;

EID: 79952156758     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109358205     Document Type: Article

References (22)

1. Craighead M., Milne R., Campbell- Wan L., et al. (2008) Characterization of a novel and selective V1B receptor antagonist. Prog Brain Res 170: 527-535. (Pubitemid 352010248)
2. de Kloet ER, Joels M., Holsboer F. (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463-475. (Pubitemid 40769171)
3. DeBold CR, Sheldon WR, DeCherney GS, et al. (1984) Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest 73: 533-538. (Pubitemid 14194634)
4. Dinan TG, Lavelle E., Scott LV, Newell-Price J., Medbak S., Grossman AB (1999) Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. J Clin Endocrinol Metab 84: 2238-2240. (Pubitemid 30647061)
5. Dinan TG, Scott LV (2005) Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin. J Anat 207: 259-264. (Pubitemid 41308808)
6. Favrod-Coune C., Raux-Demay MC, Proeschel MF, Bertagna X., Girard F., Luton JP (1993) Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Clin Endocrinol (Oxford) 38: 405-410. (Pubitemid 23105074)
7. Gijsman HJ, Cohen AF, van Gerven JM (2004) The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system. J Psychopharmacol 18: 7-13. (Pubitemid 38623086)
8. Gijsman HJ, van Gerven JM, Tieleman MC, et al. (1998) Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J Clin Psychopharmacol 18: 289-295. (Pubitemid 28353871)
9. Holsboer F. (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
10. Holsboer F., Gerken A., Steiger A., Benkert O., Muller OA, Stalla GK (1984) Corticotropin-releasing-factor induced pituitary-adrenal response in depression. Lancet 1: 55. (Pubitemid 14213504)
11. Holsboer F., Ising M. (2008) Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583: 350-357.
12. Jacobs GE, Hulskotte EGJ, Burggraaf J., et al. Safety of intravenously administered desmopressin for HPA-axis characterization in healthy volunteers, Journal of Psychopharmacology, in press.
13. Lamberts SW, Verleun T., Oosterom R., de Jong F., Hackeng WH (1984) Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 58: 298-303. (Pubitemid 14184133)
14. Oelkers W., Boelke T., Bahr V. (1988) Dose-response relationships between plasma adrenocorticotropin (ACTH). cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. J Clin Endocrinol Metab 66: 181-186. (Pubitemid 18027749)
15. Ring RH (2005) The central vasopressinergic system: examining the opportunities for psychiatric drug development. Curr Pharm Des 11: 205-225. (Pubitemid 40089841)
16. Scott LV, Dinan TG (1998) Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci 62: 1985-1998. (Pubitemid 28239711)
17. Scott LV, Medbak S., Dinan TG (1999 a) ACTH and cortisol release following intravenous desmopressin: a dose-response study. Clin Endocrinol (Oxford) 51: 653-658.
18. Scott LV, Medbak S., Dinan TG (1999 b) Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Biol Psychiatry 45: 1447-1454. (Pubitemid 29457557)
19. Smarius LJ, Jacobs GE, Hoeberechts-Lefrandt DH, et al. (2008) Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa. J Psychopharmacol 22: 426-433.
20. Spiga F., Harrison L., Macsweeney C., Thomson F., Craighead M., Lightman S (2009a) Effect of vasopressin 1b receptor blockade on the hypothalamic- pituitary-adrenal response of chronically stressed rats to a heterotypic stressor. J Endocrinol 200 (3). 285-291.
21. Spiga F., Harrison L., Wood S., et al. (2009b) Blockade of the V1b receptor reduces ACTH, but not corticosterone, secretion induced by stress without effecting basal HPA axis activity. J Endocrinol 200 (3). 273-283.
22. von Bardeleben U., Holsboer F. (1988) Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls. Prog Neuropsychopharmacol Biol Psychiatry 12 (Suppl). S165 - S187.